Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025.2. Limited Review Report Quarter And Nine Months 31.12.2025.3. Any Other Business With The Permission Of The Chair.
· Issued by Vista Pharmaceuticals Ltd. via BSE India
Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2026 ,inter alia, to consider and approve 1. Unaudited financial results for the quarter and nine months ended 31.12.2025.2. Limited Review Report quarter and nine months 31.12.2025.3. Any other business with the permission of the Chair.
